Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0012 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4267 | 0.4267 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0147 | 0.9197 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4267 | 0.4267 |
Onchocerca volvulus | 0.0012 | 0 | 0.5 | |
Onchocerca volvulus | Bile acid receptor homolog | 0.0012 | 0 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0159 | 1 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0012 | 0 | 0.5 |
Brugia malayi | RNA binding protein | 0.0074 | 0.4267 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0074 | 0.4267 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4267 | 0.4267 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0074 | 0.4267 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0147 | 0.9197 | 0.9197 |
Schistosoma mansoni | thyroid hormone receptor | 0.0159 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0074 | 0.4267 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4267 | 0.4267 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0074 | 0.4267 | 1 |
Brugia malayi | TAR-binding protein | 0.0074 | 0.4267 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4267 | 0.4267 |
Echinococcus granulosus | tar DNA binding protein | 0.0074 | 0.4267 | 0.4639 |
Echinococcus multilocularis | tar DNA binding protein | 0.0074 | 0.4267 | 0.4267 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0147 | 0.9197 | 0.9197 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.